LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β‐Catenin and NF‐κB signaling pathway

As a neuronal transmembrane protein, leucine‐rich repeat and fibronectin type‐III domain‐containing protein 2 (LRFN2) can recruit and combine with N‐methyl‐d‐aspartate receptors (NMDARs) to promote nerve growth. Genetic studies suggest that mutations in LRFN2 are associated with various cancers. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Yu, Xu, Lijuan, Wang, Jiru, Ge, Beibei, Wang, Qiuzi, Wang, Tao, Liu, Chang, Wei, Bin, Wang, Qilong, Gao, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530863/
https://www.ncbi.nlm.nih.gov/pubmed/35879265
http://dx.doi.org/10.1111/cas.15510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9530863/
https://www.ncbi.nlm.nih.gov/pubmed/35879265
http://dx.doi.org/10.1111/cas.15510

Ejemplares similares